期刊
DIAGNOSTICS
卷 12, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/diagnostics12092139
关键词
breast cancer; miR-29b; DNA methylation status; proliferation; invasion; angiogenesis; chemoresistance; radioresistance; targeted therapy
资金
- University of Ferrara [FAR2020, FAR2021, FIR2021]
miR-29b has a controversial role in breast cancer, acting both as a tumor suppressor and as an onco-miRNA. The different isoforms of miR-29b have a dual effect on breast tumor features, depending on the prevailing function, mature miR-29b expression, and breast tumor characteristics. miR-29b-3p and miR-29b1-5p play distinct roles in breast tumors with different phenotypes.
The miR-29 family comprises miR-29a, miR-29b, and miR-29c, and these molecules play crucial and partially overlapped functions in solid tumors, in which the different isoforms are variously de-regulated and mainly correlated with tumor suppression. miR-29b is the most expressed family member in cancer, in which it is involved in regulating gene expression at both transcriptional and post-transcriptional levels. This review focuses on the role of miR-29b in breast cancer, in which it plays a controversial role as tumor suppressor or onco-miRNA. Here we have highlighted the dual effect of miR-29b on breast tumor features, which depend on the prevailing function of this miRNA, on the mature miR-29b evaluated, and on the breast tumor characteristics. Remarkably, the analyzed miR-29b form emerged as a crucial element in the results obtained by various research groups, as the most abundant miR-29b-3p and the less expressed miR-29b1-5p seem to play distinct roles in breast tumors with different phenotypes. Of particular interest are the data showing that miR-29b1-5p counteracts cell proliferation and migration and reduces stemness in breast tumor cells with a triple negative phenotype. Even if further studies are required to define exactly the role of each miR-29b, our review highlights its possible implication in phenotype-specific management of breast tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据